Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy. | Cancers (Basel) | 2023 | 37190301 | PubTator, text mining | PubMed |
| Bioinformatics Approach to Identify the Influences of COVID-19 on Ischemic Stroke. | Biochem Genet | 2023 | 37184686 | PubTator, text mining | PubMed |
| Pharmacological effects of baicalin in lung diseases. | Front Pharmacol | 2023 | 37168996 | PubTator, text mining | PubMed |
| UPF1 regulates FOXO1 protein expression by promoting PBK transcription in non-small cell lung cancer. | Biochem Biophys Res Commun | 2023 | 37167719 | PubTator, text mining | PubMed |
| SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication. | Signal Transduct Target Ther | 2023 | 37160897 | PubTator, text mining | PubMed |
| Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma. | Discov Oncol | 2023 | 37160815 | PubTator, text mining | PubMed |
| Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37155150 | PubTator, text mining | PubMed |
| The roles of autophagy and mitophagy in corneal pathology: current knowledge and future perspectives. | Front Med (Lausanne) | 2023 | 37153108 | PubTator, text mining | PubMed |
| AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma. | Oncol Lett | 2023 | 37153047 | PubTator, text mining | PubMed |
| TOPK inhibits TNF-α-induced granulosa cell apoptosis via regulation of SIRT1/p53. | Biochem Biophys Res Commun | 2023 | 37148702 | PubTator, text mining | PubMed |
| NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma. | iScience | 2023 | 37123230 | PubTator, text mining | PubMed |
| Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma. | Clin Epigenetics | 2023 | 37120564 | PubTator, text mining | PubMed |
| Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases. | NPJ Parkinsons Dis | 2023 | 37117178 | PubTator, text mining | PubMed |
| Learning Representative Features by Deep Attention Network for 3D Point Cloud Registration. | Sensors (Basel) | 2023 | 37112464 | PubTator, text mining | PubMed |
| MFTR-Net: A Multi-Level Features Network with Targeted Regularization for Large-Scale Point Cloud Classification. | Sensors (Basel) | 2023 | 37112209 | PubTator, text mining | PubMed |
| Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials. | Microorganisms | 2023 | 37110338 | PubTator, text mining | PubMed |
| Discriminative analysis of schizophrenia patients using graph convolutional networks: A combined multimodal MRI and connectomics analysis. | Front Neurosci | 2023 | 37090813 | PubTator, text mining | PubMed |
| Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. | Cell Mol Biol Lett | 2023 | 37085753 | PubTator, text mining | PubMed |
| COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 | 37072858 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer. | Front Oncol | 2023 | 37064084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=13